Medsenic Partners With Phebra for the Clinical Development of the Oral Form of Arscimed® for the Treatment of Autoimmune Diseases
Exclusive licensing agreement for the development of a patented formulation of oral arsenic trioxide in…
5 years ago
Global Cathode Materials Market Report 2021: Market to Reach $22 Billion by 2027 – Developing Economies to Spearhead Future Growth – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Cathode Materials - Global Market Trajectory & Analytics" report has been added to…
5 years ago
Analytics Insight Announces ‘The 10 Most Influential Tech Leaders’ in June 2021
SAN JOSE, Calif. & HYDERABAD, India--(BUSINESS WIRE)--#Exceptionalleaders--Analytics Insight has named ‘The 10 Most Influential Tech…
5 years ago
Investigation Report on China’s Levofloxacin Market 2021-2025 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Levofloxacin Market 2021-2025" report has been added to ResearchAndMarkets.com's…
5 years ago
Wild Pinball Machine lights up PlayCroco Online Casino
Grab yourself a bumper bonus SYDNEY--(BUSINESS WIRE)--Fancy yourself as a bit of a pinball wizard?…
5 years ago
Fosun Tourism Was Recognised as An Honored Company in II-Asia Executive Team Poll Published by Institutional Investor
HONG KONG SAR - Media OutReach - 30 June 2021 - Fosun Tourism Group ("Fosun…
5 years ago
China Corn Products News Service – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Corn Products China News" newsletter has been added to ResearchAndMarkets.com's offering. Corn Products…
5 years ago
Update: PharmaJet Needle-free COVID-19 Vaccine Trial
The Future of Nucleic-Acid based Vaccination GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet®, the maker of innovative, needle-free injection…
5 years ago
Movandi and Mavenir Join Forces on 5G mmWave Open RAN Solution Powering the First Smart City in Thailand
Mavenir’s Cloud-Native, Open Architecture-Based Private Network Solution Leverages Movandi’s BeamX mmWave Technology IRVINE, Calif.--(BUSINESS WIRE)--#5g--Movandi,…
5 years ago
The Lancet Infectious Diseases Published Data from Sinovac’s Phase I/II Study, World’s First Published Study on Clinical Trial Results of a COVID-19 Vaccine in Healthy Children and Adolescents Aged 3 to 17 Years Old
- CoronaVac® is safe among the pediatric group aged 3 to 17 years old -…
5 years ago